Hosted by the China APIC Drug Association，The "China International OTC Industry Innovation and Development Summit • 2011 Boao Forum" (hereinafter referred to as the conference) hosted by Renhe Group (hereinafter referred to as the conference) was held in the world-famous Asian Boao Forum in Hainan on December 4-6。
 
Over the counter，Abbreviation as OTC)，refers to the convenience of the public for medication，Under the premise of ensuring the safety of medication，After the State Drug Administration Department regulations or after approval，Drugs that do not need a doctor or other medical professionals to write prescriptions to buy。
 
With China's reform and opening up，With the improvement of people's living standards，Volkswagen begins to pay attention to health，Pay attention to improving the quality of life，The people's demand for non -prescription drugs has also increased，China ’s non -prescription drug industry has also made great development in the development of the national economy。Especially in the last ten years，As China began to implement drug classification management，China's non -prescription drug industry has entered a new stage of rapid growth。In 2000, China's non -prescription drug market is still about 25.3 billion yuan market，But in 2009，China's non -prescription drug market Stake Sports Bettingsize My stake betting appreaches 1,20.95 billion yuan，increased by 17.20%year -on -year，increased by nearly 5 times in 10 years。
 
The development of the industry is reflected in the development of enterprises，Chinese OTC companies are also growing and developing rapidly，A group of large enterprise groups with high popularity and growth in the industry have emerged。As the organizer of this conference，Renhe Group also experienced a little -known local pharmaceutical company，The transition process of Fengyun brand in Shenzhou，Today Renhe，Create a legend of China Pharmaceutical, which has increased 70 times in sales income for 10 years，has become a listed company，9 medicines、Health product production enterprises，3 sales logistics companies，Modern Pharmaceutical Enterprise Group, which has great influence in the OTC industry in China。
 
According to the "Blue Book of the Development of China's Anti -prescription Pharmaceutical Industry" released by the China Anti -prescription Drug Association in May 2011，As the government continues to improve the regulations of the non -prescription drugs，The improvement of people's health knowledge level and changes in the concept of health care，More people will be willing to self -use the minor disease and the rehabilitation and prevention of the self -judgment of self -judgment，China's non -prescription drug development has broad prospects。It is expected to be 2020，my country's non -prescription drug market size will rank first in the world。
 
But compared with the rapid development of the entire Chinese pharmaceutical industry，There is still a gap in China's non -prescription drug industry，The growth rate of the retail market as the main carrier of the non -prescription pharmaceutical industry is significantly lower than the growth rate of the national pharmaceutical market。my country's non -prescription drug industry still has insufficient knowledge、Approval over complex、Single category、Lack of dosage type、Value of this opportunity、A series of problems such as lack of management，Opportunities for the rapid development of China's economy and the golden Stake Sports Bettingten stake sports betting appyears of the pharmaceutical industry，The non -prescription drug industry must be in line with international standard，Perform marketing model innovation、Market Resources Integration、Production method transformation，can finally achieve upgrade and leap。
 
2011 is the year of the start of the development of strategic emerging industries for decision -making and implementation of the State Council，The beginning of the golden development of the Chinese pharmaceutical industry，my country's government is planning to implement a series of effective support measures，Vigorously promote the upgrading and acceleration of the pharmaceutical industry。Value of this opportunity，China APIC Drug Association and Renhe Group jointly organized the "China International OTC Industry Innovation Development Summit • 2011 Boao Forum，Tightly surround industry policy dynamics，Pay close attention to the current status of the industry，"Innovation、Integrated、Transformation、Leap "as the theme，Active perspective industry status quo、In -depth exploring industrial policy、Efforts to build a cooperation between the Enterprise Association，Establish a platform for communication and communication through the conference，Let all circles understand the development of China's over -the -counter drug industry，Promote the continuity of China's non -prescription drug industry、Health and rapid development。
 
This conference adopts the form of the international conference keynote speech and interactive salon discussion，In addition to the theme report conference, there are also five sub -forums，respectively: China Self -Medicate Development Forum、China Pharmaceutical Distribution and Terminal format development forum、China's OTC retail development trend and strategy forum、2011 Boao prescription Medicine Summit Forum、Pharmaceutical Industry Innovation and Policy Development Forum。During the conference, the China APIC Drug Association will also hold the Fourth Fourth Executive Directors Meeting。
 
The conference invited the University of Southern California、stake sports betting appAmerican Stake Sports BettingJohnson、IMS Group and other internationally renowned medical field experts from the OTC industry、R & D、Professional interpretation of various aspects such as marketing，Annual event for the Chinese non -prescription drug industry，The conference invited the National Food and Drug Administration、China Medical Enterprise Management Association、China Innovation Preparation Industry Development Alliance、Leaders and experts from relevant national departments and industry associations such as the China Pharmaceutical and Health Division Development Foundation and other national departments and industry associations, and from Pfizer Pharmaceutical、Sino -U.S.、Xi'an Yangsen、Shi Guibao、Chinese Medicine Holdings、Kyushu Tong Group、North China Pharmaceutical and other large batches of domestic and foreign brand pharmaceutical companies attended the meeting，There is also the Institute of Economic Research from the South、Experts from research institutions in the well -known medical field of Shanghai circulation economy research institutions participated in this event，At the same time，There are more than 1,000 in this conference from the industry OTC manufacturers and medical circulation、Brand chain、Industry representatives in the marketing terminals and other fields participate，The guests and representatives of the meeting will discuss the forward -looking vision and pragmatic position to discuss the medical circulation of the new medical reform、Pharmaceutical terminal、Pharmaceutical chain and other non -prescription pharmaceutical industries in the non -prescription pharmaceutical industry，The Road to Business Development，Exchange practice experience with face -to -face、Discuss the win -win plan of the industry。
 
This year is the beginning of the "Twelfth Five -Year Plan"，It is also the year of the three -year task of the reform of the medical and health system，The basic drug system is gradually implementing，Drug price management measures are increasingly adjusted and perfect，Community medical and medical insurance policy measures are substantially My stake betting apppromoted。My stake betting appThe environment of my country's medical reform is in the environment.，It also makes non -prescription drug companies face more severe challenges。China International OTC Industry Innovation and Development Summit was successfully held，It will definitely help condense the consensus of the development strategy of self -medical and therapy in the new medical reform situation，Finding the confidence of strengthening brand building in the non -prescription drug industry，Promoting the sustainable development of my country's self -medical and therapy。
 
The organizing committee of the conference has done a good job of preparations for the participants from various places，We will use the most exciting meeting content、The most complete service provides a high -level learning and communication event for participants，Contributions to the rapid transformation and sustainable development of China's non -prescription drug industry。
 
China International OTC Industry Innovation and Development Summit • 2011 Boao Forum Organizing Committee